Intraluminal pathway protected
In a recent publication Caillouet (2012) describes a project to protect the intraluminal pathway with zero fluid displacement IV connectors. Caillouet explains “the infusion therapy team piloted a zero fluid displacement (ZFD) connector based on the design of the ZFD, which appeared uniquely suited to CR-BSI prevention”. Results from the project demonstrated a CRBSI reduction rate from 4.2 (2,331 catheter days) to 0.4 (2,477 catheter days) when the ZFD connector was used. In a recent publication Caillouet (2012) describes a project to protect the intraluminal pathway with zero fluid displacement IV connectors. Caillouet explains “the infusion therapy team piloted a zero fluid displacement (ZFD) connector based on the design of the ZFD, which appeared uniquely suited to CR-BSI prevention”.
This article was cited on IVTEAM.
Reference
Caillouet, B. (2012) Protection of Intraluminal Pathway with Zero Fluid Displacement Connector Reduces Catheter-Related Bloodstream Infections in a Comprehensive Cancer Center. The Journal of the Association for Vascular Access. 17(2), p.86-89.
